Summary
This prediction ended on 31.12.18 with a price of €60.56. The prediction for Bayer AG disappointed with a performance of -21.17%. christoph_elias has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -5.011% | -5.011% | 78.138% | -28.880% |
| iShares Core DAX® | -1.306% | -0.778% | 9.149% | 57.505% |
| iShares Nasdaq 100 | 1.979% | -2.045% | 6.569% | 90.022% |
| iShares Nikkei 225® | 0.593% | 6.713% | 31.580% | 65.481% |
| iShares S&P 500 | 1.425% | -0.477% | 3.616% | 62.099% |
Comments by christoph_elias for this prediction
In the thread Bayer AG diskutieren
christoph-elias stimmt der Buy-Einschätzung von DirectorDealer zu
christoph-elias stimmt am 27.09.2018 der Buy-Einschätzung von DirectorDealer mit dem Kursziel 79,926€ zu.
Überschrift: Director's Dealing: Buy
(Laufzeit überschritten)